(Q35688515)

9 August 2017

1 reference

title

The relevance of complement to virus biology (English)

1 reference

9 August 2017

David J Blackbourn

3

0 references

author name string

Clare E Blue

series ordinal

1

1 reference

PubMed ID

15015499

9 August 2017

O Brad Spiller

series ordinal

2

1 reference

PubMed ID

15015499

9 August 2017

language of work or name

English

0 references

publication date

1 February 2004

1 reference

9 August 2017

9

1 reference

inferred from page(s)

published in

Virology

1 reference

9 August 2017

319

1 reference

9 August 2017

176-184

1 reference

9 August 2017

2

1 reference

Herpesvirus saimiri has a gene specifying a homologue of the cellular membrane glycoprotein CD59

9 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.029

Binding of human and animal immunoglobulins to the IgG Fc receptor induced by human cytomegalovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.029

Decay-accelerating factor (CD55), a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.029

Complement receptor mediates enhanced flavivirus replication in macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.029

Complement activation by recombinant adenoviruses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.029

Lysis of RNA tumor viruses by human serum: direct antibody-independent triggering of the classical complement pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.029

Humoral response to herpes simplex virus is complement-dependent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.029

In vitro neutralization of HSV-2: Inhibition by binding of normal IgG and purified Fc to virion Fc receptor (FcR)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.029

Complement factors and their receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.029

Virus complement evasion strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.029

Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.029

Glycoprotein C of herpes simplex virus 1 acts as a receptor for the C3b complement component on infected cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.029

CD46 is a cellular receptor for group B adenoviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.029

C3d enhancement of neutralizing antibodies to measles hemagglutinin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.029

Human Herpesvirus 6 and Measles Virus Employ Distinct CD46 Domains for Receptor Function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.029

Structure of complement receptor (CR) 2 and CR2-C3d complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.029

Human mannose-binding protein functions as an opsonin for influenza A viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.029

C4A deficiency and nonresponse to hepatitis B vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.029

The complement system as a therapeutic target in autoimmunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.029

The interaction of glycoprotein C of herpes simplex virus types 1 and 2 with the alternative complement pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.029

Vaccinia virus complement-control protein prevents antibody-dependent complement-enhanced neutralization of infectivity and contributes to virulence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.029

C5a and C5a(desArg) enhance the susceptibility of monocyte-derived macrophages to HIV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.029

Critical role of complement and viral evasion of complement in acute, persistent, and latent gamma-herpesvirus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.029

Defective phagocytosis by human monocyte/macrophages following HIV-1 infection: underlying mechanisms and modulation by adjunctive cytokine therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.029

Anaphylatoxins and infectious and non-infectious inflammatory diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.029

Structure-function relationships of complement receptor type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.029

‘Complementing’ viral infection: mechanisms for evading innate immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.029

Herpesviral Fc receptors and their relationship to the human Fc receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.029

Cardiovirulent coxsackieviruses and the decay-accelerating factor (CD55) receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.029

Structure-function studies of the receptors for complement C1q.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.029

Regulation of complement activity by vaccinia virus complement-control protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.029

Protection of mice against Sendai virus pneumonia by non-neutralizing anti-F monoclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.029

B cells of HIV-1-infected patients bind virions through CD21-complement interactions and transmit infectious virus to activated T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.029

Epstein-Barr virus regulates activation and processing of the third component of complement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.029

Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) open reading frame 4 protein (kaposica) is a functional homolog of complement control proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.029

Mechanism of host cell protection from complement in murine cytomegalovirus (CMV) infection: identification of a CMV-responsive element in the CD46 promoter region

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.029

Mapping the binding domains on decay accelerating factor (DAF) for haemagglutinating enteroviruses: implications for the evolution of a DAF-binding phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.029

A transgenic mouse model for measles virus infection of the brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.029

Human monoclonal antibodies to the human immunodeficiency virus type 1 (HIV-1) transmembrane glycoprotein gp41 enhance HIV-1 infection in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.029

HTLV-I activates complement leading to increased binding to complement receptor-positive cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.029

Human immunodeficiency virus type 1 incorporates both glycosyl phosphatidylinositol-anchored CD55 and CD59 and integral membrane CD46 at levels that protect from complement-mediated destruction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.029

The mannan-binding lectin-associated serine proteases (MASPs) and MAp19: four components of the lectin pathway activation complex encoded by two genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.029

Vesicular removal by oligodendrocytes of membrane attack complexes formed by activated complement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.029

Adenovirus type 11 uses CD46 as a cellular receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.029

Complement C4 deficiency and HLA homozygosity in patients with frequent intraoral herpes simplex virus type 1 infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.029

Membrane-targeted complement inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.029

HIV and HIV-infected cells differentially activate the human complement system independent of antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.029

Anti-cellular antibodies in sera from vaccinated macaques can induce complement-mediated virolysis of human immunodeficiency virus and simian immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.029

Antibody-independent activation of the classical complement pathway by cytomegalovirus-infected fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.029

Altered expression of host-encoded complement regulators on human cytomegalovirus-infected cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.029

Echoviruses and coxsackie B viruses that use human decay-accelerating factor (DAF) as a receptor do not bind the rodent analogues of DAF

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.029

Functional Activity of the Complement Regulator Encoded by Kaposi's Sarcoma-associated Herpesvirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.029

Complement regulation by Kaposi's sarcoma-associated herpesvirus ORF4 protein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.029

Interaction of several complement proteins with gp120 and gp41, the two envelope glycoproteins of HIV-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.029

Efficient destruction of human immunodeficiency virus in human serum by inhibiting the protective action of complement factor H and decay accelerating factor (DAF, CD55).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.029

Role of complement in HIV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.029

Complement can neutralize HIV-1 plasma virus by a C5-independent mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.029

SLAM (CDw150) is a cellular receptor for measles virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.029

Interaction of C1q and mannan-binding lectin with viruses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.029

Epstein-Barr virus infection of polarized tongue and nasopharyngeal epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.029

Antibody-induced internalization of viral glycoproteins and gE-gI Fc receptor activity protect pseudorabies virus-infected monocytes from efficient complement-mediated lysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.029

Effects of innate immunity on herpes simplex virus and its ability to kill tumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.029

Complement. First of two parts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.029

Current status and prospects of studies on human genetic alleles associated with hepatitis B virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.029

Phylogenetic aspects of the complement system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.029

Herpes simplex virus type 1 glycoprotein gC mediates immune evasion in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.029

Murine gammaherpesvirus 68 encodes a functional regulator of complement activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.029

7 January 2021

inferred from DOI database lookup

Viral cell entry induced by cross-linked decay-accelerating factor

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.029

7 January 2021

inferred from DOI database lookup

Host modification of Sindbis virus sialic acid content influences alternative complement pathway activation and virus clearance

1 reference

12 December 2020

The complement control protein homolog of herpesvirus saimiri regulates serum complement by inhibiting C3 convertase activity

1 reference

12 December 2020

Glycoprotein C of herpes simplex virus 1 is an inhibitor of the complement cascade

1 reference

12 December 2020

Human complement component C1q inhibits the infectivity of cell-free HTLV-I.

1 reference

12 December 2020

Elimination of terminal complement intermediates from the plasma membrane of nucleated cells: the rate of disappearance differs for cells carrying C5b-7 or C5b-8 or a mixture of C5b-8 with a limited number of C5b-9

1 reference

12 December 2020

Interaction of vaccinia virus complement control protein with human complement proteins: factor I-mediated degradation of C3b to iC3b1 inactivates the alternative complement pathway.

1 reference

12 December 2020

Transgenic mice expressing human measles virus (MV) receptor CD46 provide cells exhibiting different permissivities to MV infections.

1 reference

12 December 2020

Elimination of terminal complement complexes in the plasma membrane of nucleated cells: influence of extracellular Ca2+ and association with cellular Ca2+

1 reference

12 December 2020

Host cell-derived complement control proteins CD55 and CD59 are incorporated into the virions of two unrelated enveloped viruses. Human T cell leukemia/lymphoma virus type I (HTLV-I) and human cytomegalovirus (HCMV).

1 reference

12 December 2020

Hydrodynamic, electron microscopic, and ligand-binding analysis of the Epstein-Barr virus/C3dg receptor (CR2).

1 reference

12 December 2020

Therapeutic inhibition of the complement system.

1 reference

12 December 2020

Interactions of a nonneutralizing IgM antibody and complement in parainfluenza virus neutralization

1 reference

12 December 2020

10.1016/J.VIROL.2003.11.029

Identifiers

DOI

1 reference

9 August 2017

0 references

1 reference

PubMed ID

15015499